DEEPEXI TECH to Raise HK$401.70 Million Through 7.94 Million H-Share Placement at 19.78% Discount

Bulletin Express
05/21

DEEPEXI Technology Co., Ltd. (DEEPEXI TECH) has entered into a placing agreement with CLSA Limited (sole overall coordinator) and four other placing agents to issue 7.94 million new H shares under its existing 20% general mandate.

The new shares will be offered at HK$50.58 each, representing a 19.78% discount to the 20 May 2026 closing price of HK$63.05 and a 19.60% discount to the five-day average of HK$62.91. The placement represents 2.431% of the current issued share capital and 2.374% of the enlarged share base.

Gross proceeds are expected to reach HK$401.70 million, with net proceeds estimated at HK$395.00 million, implying a net issue price of HK$49.73 per share. Allocation of the funds is planned as follows: • 70% for overseas market expansion and localisation, including new regional offices, marketing initiatives, and enhancement of service and delivery capabilities. • 20% for strategic investments and acquisitions that align with DEEPEXI TECH’s core business and international growth strategy. • 10% for working capital and general corporate purposes.

Completion is contingent on conditions such as Hong Kong Stock Exchange listing approval and absence of any material adverse change before closing, which is expected no later than 29 May 2026. The company has agreed to a 45-day lock-up period on further equity issuance, excluding the current placement.

Post-placement, total issued shares will rise from 326.63 million to 334.57 million. Public float will remain above the required 15%, with placees collectively holding approximately 2.37% of the enlarged share capital.

No other shares have been issued under the current general mandate. DEEPEXI TECH last raised equity in October 2025, securing HK$657.28 million in net proceeds from its Hong Kong listing.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10